Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/0b5f01c1d0704f40a6384d79fd934ef2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:0b5f01c1d0704f40a6384d79fd934ef2 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:0b5f01c1d0704f40a6384d79fd934ef22021-11-04T17:00:08ZIntratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer10.1136/jitc-2021-0028762051-1426https://doaj.org/article/0b5f01c1d0704f40a6384d79fd934ef22021-09-01T00:00:00Zhttps://jitc.bmj.com/content/9/9/e002876.fullhttps://doaj.org/toc/2051-1426Paola CappelloMaurizio MartiniAldo ScarpaStefano UgelFrancesco De SanctisGiampaolo TortoraEmilio BriaVincenzo CorboCarmine CarboneGeny PiroAntonio AgostiniPietro DelfinoVincenzo NascaFrancesco SpallottaClaudio SetteBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Paola Cappello Maurizio Martini Aldo Scarpa Stefano Ugel Francesco De Sanctis Giampaolo Tortora Emilio Bria Vincenzo Corbo Carmine Carbone Geny Piro Antonio Agostini Pietro Delfino Vincenzo Nasca Francesco Spallotta Claudio Sette Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer |
| format |
article |
| author |
Paola Cappello Maurizio Martini Aldo Scarpa Stefano Ugel Francesco De Sanctis Giampaolo Tortora Emilio Bria Vincenzo Corbo Carmine Carbone Geny Piro Antonio Agostini Pietro Delfino Vincenzo Nasca Francesco Spallotta Claudio Sette |
| author_facet |
Paola Cappello Maurizio Martini Aldo Scarpa Stefano Ugel Francesco De Sanctis Giampaolo Tortora Emilio Bria Vincenzo Corbo Carmine Carbone Geny Piro Antonio Agostini Pietro Delfino Vincenzo Nasca Francesco Spallotta Claudio Sette |
| author_sort |
Paola Cappello |
| title |
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer |
| title_short |
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer |
| title_full |
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer |
| title_fullStr |
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer |
| title_full_unstemmed |
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer |
| title_sort |
intratumoral injection of tlr9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-pd1 in pancreatic cancer |
| publisher |
BMJ Publishing Group |
| publishDate |
2021 |
| url |
https://doaj.org/article/0b5f01c1d0704f40a6384d79fd934ef2 |
| work_keys_str_mv |
AT paolacappello intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT mauriziomartini intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT aldoscarpa intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT stefanougel intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT francescodesanctis intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT giampaolotortora intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT emiliobria intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT vincenzocorbo intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT carminecarbone intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT genypiro intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT antonioagostini intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT pietrodelfino intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT vincenzonasca intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT francescospallotta intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer AT claudiosette intratumoralinjectionoftlr9agonistpromotesanimmunopermissivemicroenvironmenttransitionandcausescooperativeantitumoractivityincombinationwithantipd1inpancreaticcancer |
| _version_ |
1718444631594631168 |